Dolphin Medical Services Ltd
Fundamental Score
Dolphin Medical Services Ltd Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of DOLPHMED across key market metrics for learning purposes.
Positive Indicators
3 factors identified
Consistent Growth Track Record (34.08% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model and market opportunity execution over time.
Conservative Debt Levels (D/E: 0.08)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
10 factors identified
Below-Average Return on Equity (-0.30%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (-0.18%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation. Review business model and competitive positioning.
Margin Pressure Concerns (-198.37%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges. Monitor for operational improvements.
Profit Decline Concern (-50.00%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes. Monitor for recovery signs and management guidance.
Revenue Contraction (-28.00%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions and competitive positioning. Monitor recovery strategies.
Negative Free Cash Flow (₹-0.01 Cr over 5Y)
Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.
Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.
Low Promoter Commitment (26.44%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment and long-term vision alignment.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.
Very Low ROE
Observation: Poor capital utilization and shareholder returns.
Analysis: ROE below 5% suggests significant inefficiencies in capital deployment.
Small Market Cap
Observation: Higher investment risk due to limited size.
Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.
Financial Statements
Comprehensive financial data for Dolphin Medical Services Ltd
About DOLPHMED
Business Overview
Dolphin Medical Services Limited engages in the provision of diagnostics and other allied services in India. Dolphin Medical Services Limited was incorporated in 1992 and is based in Vijayawada, India.
Company Details
Key Leadership
DOLPHMED Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Dolphin Medical Services Ltd (DOLPHMED)?
As of 19 Jan 2026, 10:09 am IST, Dolphin Medical Services Ltd (DOLPHMED) is currently trading at ₹3.10. The stock has a market capitalization of ₹3.60 (Cr).
Is DOLPHMED share price Overvalued or Undervalued?
DOLPHMED is currently trading at a P/E ratio of 0.00x, compared to the industry average of 39.28x. Based on this relative valuation, the stock appears to be Fairly Valued against its sector peers.
What factors affect the Dolphin Medical Services Ltd share price?
Key factors influencing DOLPHMED's price include its quarterly earnings growth (Sales Growth: -28.00%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Dolphin Medical Services Ltd a good stock for long-term investment?
Dolphin Medical Services Ltd shows a 5-year Profit Growth of 13.97% and an ROE of -0.30%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.08 before investing.
How does Dolphin Medical Services Ltd compare with its industry peers?
Dolphin Medical Services Ltd competes with major peers in the Healthcare Service Provider. Investors should compare DOLPHMED's P/E of 0.00x and ROE of -0.30% against the industry averages to determine its competitive standing.
What is the P/E ratio of DOLPHMED and what does it mean?
DOLPHMED has a P/E ratio of N/Ax compared to the industry average of 39.28x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹N/A for every ₹1 of annual earnings.
How is DOLPHMED performing according to Bull Run's analysis?
DOLPHMED has a Bull Run fundamental score of 16.4/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does DOLPHMED belong to?
DOLPHMED operates in the Healthcare Service Provider industry. This classification helps understand the competitive landscape and sector-specific trends affecting Dolphin Medical Services Ltd.
What is Return on Equity (ROE) and why is it important for DOLPHMED?
DOLPHMED has an ROE of -0.30%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Dolphin Medical Services Ltd generates profits from shareholders' equity.
How is DOLPHMED's debt-to-equity ratio and what does it indicate?
DOLPHMED has a debt-to-equity ratio of 0.08, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.
What is DOLPHMED's dividend yield and is it a good dividend stock?
DOLPHMED offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.
How has DOLPHMED grown over the past 5 years?
DOLPHMED has achieved 5-year growth rates of: Sales Growth 34.08%, Profit Growth 13.97%, and EPS Growth 13.97%.
What is the promoter holding in DOLPHMED and why does it matter?
Promoters hold 26.44% of DOLPHMED shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is DOLPHMED's market capitalization category?
DOLPHMED has a market capitalization of ₹4 crores, placing it in the Small-cap category.
How volatile is DOLPHMED stock?
DOLPHMED has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for DOLPHMED?
DOLPHMED has a 52-week high of ₹N/A and low of ₹N/A.
What is DOLPHMED's operating profit margin trend?
DOLPHMED has a 5-year average Operating Profit Margin (OPM) of -198.37%, indicating the company's operational efficiency.
How is DOLPHMED's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of -28.00% and YoY Profit Growth of -50.00%.
What is the institutional holding pattern in DOLPHMED?
DOLPHMED has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the stock.